ACR Convergence 2021 Archives - Page 61 of 132

Abstract Number: 0071

Damage Accrual Measured by DIAPS in Antiphospholipid Antibody (aPL)-positive Patients: Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
Abstract Number: 0646

Dark Adaptometry Screening for Hydroxychloroquine Retinopathy: A Pilot Study
Abstract Number: 0904

Data-driven Definitions Based on Inflammatory Lesions for a Positive MRI of the Spine Consistent with Axial Spondyloarthritis
Abstract Number: 0975

Data-driven MRI Definitions for Active and Structural Sacroiliac Joint Lesions in Juvenile Spondyloarthritis Typical of Axial Disease
Abstract Number: 1311

De Novo Psoriasis Can Be Reported at Any Timepoint in Early Axial Spondyloarthritis: An Analysis of 6 Years of Follow-up of the DESIR Cohort
Abstract Number: 0736

Decrease in Prevalence of Self-Reported Anxiety or Depression in Persons with Osteoarthritis After Total Knee Arthroplasty: The BEST KNEE Cohort Study
Abstract Number: 1508

Decrease of Angiogenic T Cells Associated to the Presence of Interstitial Lung Disease in Patients with Connective Tissue Diseases
Abstract Number: 0775

Decreased HDL Levels and Antioxidant Function in Juvenile Dermatomyositis
Abstract Number: 0785

Decreased Peripheral Blood Natural Killer Cell Count in Untreated Juvenile Dermatomyositis Is Associated with Muscle Weakness
Abstract Number: 1411

Decreased Use of Ultrasound Fast-track Pathways of Giant Cell Arteritis Due to COVID-19 Pandemic: A Potential Risk for Permanent Visual Loss
Abstract Number: 0059

Deep Immune Cell Profiling of Tissue Microenvironment Using Imaging Mass Cytometry in Psoriatic Disease
Abstract Number: 0152

Deep Learning-Derived Chest Radiograph Scores in COVID-19 in Rheumatic Disease Patients versus General Population Comparators
Abstract Number: 0386

Delay to Diagnosis in Axial Spondyloarthritis: The Gap Is Closing, but Persistent Association with Severe Disease
Abstract Number: 1879

Delayed Diagnosis of IgG4 Related Disease Is Associated with Worse Outcome: A Retrospective, Real-life Observational Study
Abstract Number: 0288

Demographic, Lifestyle, and Clinical Risk Factors for Rheumatoid Arthritis-Associated Bronchiectasis: Role of RA-related Autoantibodies
Abstract Number: L07

Depletion of KLRG1+ T Cells in a First-in-human Clinical Trial of ABC008 in Inclusion Body Myositis (IBM)
Abstract Number: 0655

Depression and Fatigue: Two Forgotten Associated Comorbidities in Patients with Rheumatoid Arthritis
Abstract Number: 0890

Depression Is Associated with Frailty in Systemic Lupus Erythematosus Patients: Multicenter Retrospective Analysis Using Systemic Lupus Erythematosus International Collaborating Clinics-Frailty Index
Abstract Number: 0297

Describing the Disease Burden of Primary Sjögren’s Syndrome Patients: Results from a Real-World Survey in the US
Abstract Number: 0142

Description of a Scleroderma Cohort and Management of Lung Disease Risk at a Rural Academic Medical Center
Abstract Number: 1880

Description of an Internet-Based Cohort with a Self-Reported Diagnosis of Polyarteritis Nodosa
Abstract Number: 1806

Designing a Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Investigate the Effect of Guselkumab (TREMFYA®/sup>) Dosing Interval in Psoriatic Arthritis Patients with Inadequate Response to Tumor Necrosis Factor Inhibition
Abstract Number: 0697

Detection of Autoantibodies Against Muscle-Specific Four-and-a-Half-LIM Domain 1 (FHL1) in Inflammatory Myopathies: Results from a Single-Center Cohort
Abstract Number: 1919

Detection of Radiographic Sacroiliitis with an Artificial Neural Network in Patients with Suspicion of Axial Spondyloarthritis
Abstract Number: 0886

Determinants of Accessing Social and News Media and Experiencing Negative Impacts During COVID-19 in an International SLE Sample
Abstract Number: 1467

Determinants of Cervical Cancer Screening Patterns Among Women with Systemic Lupus Erythematosus
Abstract Number: 0567

Determinants of Health-Related Quality of Life in Spondyloarthritis and Comparison with Chronic Low Back Pain – Results from a Nation-Wide Study
Abstract Number: 1179

Determining Faculty vs. Fellow Preferences for ROSCE Milestone Assessments; Is It Time for a Change in Needs Assessment?
Abstract Number: 1352

Deucravacitinib Efficacy in Psoriatic Arthritis (PsA) by Baseline DMARD Use: Exploratory Analysis from a Phase 2 Study
Abstract Number: 0289

Developing a Score to Predict Preclinical Interstitial Lung Disease in Patients with Rheumatoid Arthritis – a Cross-Sectional Study from the ESPOIR Cohort
Abstract Number: 0258

Developing Electronic Health Record Algorithms That Accurately Identify Patients with Juvenile Idiopathic Arthritis
Abstract Number: 0265

Development and Preliminary Acceptability of JIActiv, a Social Media-Based Program Promoting Engagement in Physical Activity Among Young People Living with Juvenile Idiopathic Arthritis
Abstract Number: 1419

Development and Validation of a Patient Reported Outcome Measure for Giant Cell Arteritis
Abstract Number: 0420

Development and Validation of a Simulation Model for Maintenance Treatment in ANCA-Associated Vasculitis
Abstract Number: 1438

Development of a Computationally Designed, Hyperstable Dual Inhibitor of the IL-2 and IL-15 Receptors: A Novel Therapeutic Candidate for Inflammatory Conditions
Abstract Number: 0157

Development of a Deep Learning Algorithm for the Detection of Sacroiliitis on MRI in Patients with Active Axial Spondyloarthritis
Abstract Number: 1215

Development of a Multivariable Prediction Model for Treatment Response to Etanercept in a Multi-centre Cohort of Patients with Established RA
Abstract Number: 0063

Development of a Novel Cartilage Model Co-cultured with Conditioned Medium from Th17 Cells to Explore the Effect of IL-17A on Joint Tissue Remodeling
Abstract Number: 1576

Development of a Plain Radiographic Scoring System for New Bone Formation in Gout
Abstract Number: 0532

Development of a Predictive Tool for the Rapid Progressive Knee Osteoarthritis Phenotype: Data from the Osteoarthritis Initiative
Abstract Number: 0761

Development of a Symptom Diary for Use in Patients with Sjogren’s Syndrome
Abstract Number: 1526

Development of Antinuclear Antibodies and Systemic Lupus Erythematosus in Patients on Tumor Necrosis Factor α Inhibitor Therapy
Abstract Number: 0524

Development of Biomarker Models to Identify HLA-related Microbiome Associations in Anti-Ro+ Mothers of Children with Neonatal Lupus
Abstract Number: 0244

Development of Candidate Criteria for Axial Disease in Juvenile Spondyloarthritis: An International Collaboration
Abstract Number: 0149

Development of Joint Effusion, Hyperperfusion and Enthesitis After One Hour of Age-and Gender Adjusted Weight Training
Abstract Number: 0676

Development, Refinement, and Validation of an Emergency Department Gout Flare Electronic Medical Record Alert
Abstract Number: 0163

Diagnosis of Giant Cell Arteritis in Spain: Data from the ARTESER Registry
Abstract Number: 0826

Diagnosis, Treatment and Utilization Changes in Rheumatoid Arthritis Patients Before and During COVID-19
Abstract Number: 1582

Diagnostic Accuracy and Reliability of Conventional Radiography of the Knee in Calcium Pyrophosphate Deposition Disease by Using New Definitions: An Ancillary Study of the OMERACT Ultrasound – CPPD Group
Abstract Number: 0714

Diagnostic Accuracy of Electromyogram for Myositis
Abstract Number: 0425

Diagnostic Accuracy of Muscle MRI for Muscular Vasculitis in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis: A Pilot Study
Abstract Number: 0651

Diagnostic Approach to Identifying Small Fiber Neuropathy in Patients with Sarcoidosis
Abstract Number: 0786

Diagnostic Utility of FibroScan in Screening for Liver Injury in Patients with Inflammatory Arthritis on Treatment with Methotrexate (MTX)
Abstract Number: 0383

Differences Between Male vs. Female Presenting with Back Pain in an Integrated Delivery System
Abstract Number: 0598

Differences in Discoid Lupus Erythematosus Skin Lesion Distribution and Characteristics in Black and Non-Black Patients: A Retrospective Cohort Study
Abstract Number: 1239

Differences in Patient-Reported Outcomes Between Those Who Stay in Remission and Those Who Have Disease-Worsening Following Therapy Withdrawal in Patients with Rheumatoid Arthritis
Abstract Number: 1354

Differences in Real-World Patient Characteristics of 8921 Patients with Psoriasis with and Without Comorbid Psoriatic Arthritis Using the UK BADBIR Database
Abstract Number: 0757

Different Versions of the Patient Global Question in Rheumatoid Arthritis – Does It Really Matter? – Results of a Multi-center Observational Study
Abstract Number: 0102

Differential Impact of TNFi, JAKi and Rituximab on the Outcome of SARS-CoV-2 Infection in RMD Patients
Abstract Number: 0011

Differential Inflammation-mediated Function of Prokineticin 2 in the Synovial Fibroblasts of Patients with Rheumatoid Arthritis Compared to Osteoarthritis
Abstract Number: 1872

Differentiating Primary Central Nervous System Vasculitis from Non-inflammatory Intracranial Vasculopathy
Abstract Number: 0166

Digital Extensor Paratenonitis Is Frequent in Early Rheumatoid Arthritis
Abstract Number: 1275

Digital Solution for Collection of Patient-reported Outcome Measures in Patients with Systemic Lupus Erythematosus: A Randomised, Crossover, Agreement Study
Abstract Number: 0800

Digital Spatial Profiling Reveals Distinct Synovial Tissue Transcriptomic Signature of Sustained Disease Remission in Rheumatoid Arthritis Patients at Risk of Disease Flare After Treatment Tapering or Discontinuation
Abstract Number: 0170

Direct and Conditional Effects of Epicardial Adipose Tissue Volume on Coronary Plaque Progression in Rheumatoid Arthritis
Abstract Number: 0663

Disappearing Digits: A National Retrospective Matched Cohort Study Examining the Risk of Lower Extremity Amputation in Gout
Abstract Number: 1252

Discontinuation of TNFi Treatment Among Rheumatoid Arthritis Patients with a Molecular Signature of Non-response to Tumor Necrosis Factor-ɑ Inhibitor Therapies
Abstract Number: 1830

Discontinuation of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis and Psoriasis
Abstract Number: 0827

Discontinuation Rate of Tofacitinib as Monotherapy Is Similar Compared to Combination Therapy with Methotrexate in Rheumatoid Arthritis Patients: Pooled Data from Two Rheumatoid Arthritis Registries in Canada
Abstract Number: 1217

Discontinuation Rate of Tofacitinib Is Similar When Compared to TNF Inhibitors in Rheumatoid Arthritis Patients: Pooled Data from Two Rheumatoid Arthritis Registries in Canada
Abstract Number: PP10

Discovering ‘I’ Through Interaction with Support Group Members: A Place of Empathy That Transcends the Limitations of Words
Abstract Number: 1105

Discovering Variants in Suspected Monogenic Systemic Inflammatory Disease: An Adult Case Series
Abstract Number: 0693

Discovery of Antigen Specific CD4+ T Cells in Anti-HMGCR-positive Immune Mediated Necrotizing Myopathy
Abstract Number: 0916

Disease Activity and Inflammation in Axial Spondyloarthritis Patients Who Did Not Experience Flares Following Certolizumab Pegol Withdrawal, Dose Reduction or Dose Continuation
Abstract Number: 1730

Disease Activity and Outcome in Pregnancies of Patients with SpA – Data from the German Pregnancy Register RHEKISS
Abstract Number: 1782

Disease Activity in Psoriatic Arthritis Patients with Enthesitis Across Different Therapies
Abstract Number: 1103

Disease Associations with Very High Serum IgG4 Concentrations: A Retrospective Multi-Center Study
Abstract Number: 1854

Disease Characteristics and Social Determinants in African Americans with Systemic Sclerosis: A Single Center Experience
Abstract Number: 1116

Disease Characteristics of Steroid-Induced Spinal Epidural Lipomatosis: A Systematic Review
Abstract Number: 0363

Disease Course and Disease Burden in Patients with Axial Spondyloarthritis: Results from 5-year Multicountry Prospective Observational Study
Abstract Number: 1618

Disease Flares in CANDLE/PRAAS with Dose Reductions of Baricitinib
Abstract Number: 0888

Disease Flares in Lupus Are Concordant with Ruminococcus Blautia Gnavus Blooms Within Unstable Gut Microbiota Communities
Abstract Number: 1270

Disease Severity and Healthcare Costs Associated with Chronic Kidney Disease in Patients with Systemic Lupus Erythematosus
Abstract Number: 0473

Disease-Associated Microglia Are Implicated in Neuropsychiatric Manifestations of Systemic Lupus Erythematosus
Abstract Number: 0604

Disparities in Burden of Disease in Patients with RA Across Racial and Ethnic Groups
Abstract Number: 0164

Disrupted Executive Control Network Structural-Functional Integration Is Associated with Inferior Performance of Cognitive Switching Tasks in Patients with Systemic Lupus Erythematosus (SLE)
Abstract Number: 0946

Distinct Lipidomic Signatures in Synovium and Synovial Fluid of Patients with Rheumatoid Arthritis versus Psoriatic Arthritis
Abstract Number: 0216

Distribution of Medial Femur and Tibia Cartilage Volume Change over 48 Months on MRI: Comparison Among Kellgren-Lawrence Grades
Abstract Number: 0007

Divergent Reactivities of Rheumatoid Factors and Anti-Modified Protein Antibodies Converge on IgG Epitopes
Abstract Number: 0587

DMARD Use in Medicare Patients with Rheumatoid Arthritis and Risk of Long-Term Opioid Use
Abstract Number: 1041

Do Cancer Risks Increased in the Five Major Autoimmune Diseases? A Large Cohort Study in China
Abstract Number: 1587

Do Physical Therapists Use Recommended Treatments for Chronic Low Back Pain?
Abstract Number: 0313

Do Primary Sjögren’s Syndrome Patients with Normal Major Salivary Gland Ultrasound Have Less Active Disease?
Abstract Number: 1520

Do Specific Rheumatic Autoantibodies Predict Severity or Time to Onset of Immune-related Adverse Events from Checkpoint Inhibitors?
Abstract Number: 0161

Does 18F-FDG-PET/MRI Add Metabolic Information to Anatomic Image in Childhood-onset Takayasu’s Arteritis Patients? A Multicenter Case Series
Abstract Number: 1542

Does Adjustment to Dosing and Timing of Immunomodulatory Drugs Impact Immunogenicity of COVID19 Vaccines in Patients with Autoimmune and Inflammatory Rheumatic Disease (AIIRD)?
Abstract Number: 1229

Does BMI Influence the Efficacy of Subcutaneous or Intravenous Abatacept in Patients with RA in Routine Clinical Practice? A Post Hoc Analysis of Two Real-world Observational Studies
Abstract Number: 1098

Does Cancer Masquerade as Sarcoidosis?
Abstract Number: 0991

Does Diet Affect Gout Risk Differently Among Genetically Predisposed Women?: Prospective Female Cohort Study Findings over 34 Years
Abstract Number: 0626

Does Higher Quality of Care in SLE Translate to Better Patient Outcomes?
Abstract Number: 0902

Does Imaging of the Sacroiliac Joint and Spine Differ in Patients Presenting with Undiagnosed Back Pain and Psoriasis, Acute Anterior Uveitis, and Colitis: An Inception Cohort Study
Abstract Number: 1903

Does Limited Stair Climbing Lead to Poor Future Health? The Relationship Between Short-term Trajectories of Stair Climbing Frequency and Incident Slow Gait Speed over 1 and 2 Years in Adults with Knee Osteoarthritis
Abstract Number: 0864

Does Obesity Affect Disease Activity Outcomes in Systemic Lupus Erythematosus?
Abstract Number: 0672

Does Obesity Affect Gout Risk Differently Among Genetically Predisposed Individuals?: Sex-Specific Prospective Cohort Study Findings over >32 Years
Abstract Number: 1918

Don’t Forget About the Arthritis in RA-ILD! Impact of Pulmonary and RA Disease Severity on Survival
Abstract Number: 0724

Dose (Exposure) Efficacy Response of Tanezumab Following Intravenous and Subcutaneous Administration Across Phase 2 and Phase 3 Studies in Patients with Osteoarthritis of Hip and Knee
Abstract Number: 0364

Dose Tapering of TNF Inhibitors in Patients with Axial Spondyloarthritis in Routine Care – 2-year Clinical and MRI Outcomes and Predictors of Successful Tapering
Abstract Number: 1483

Down-regulation of Hematopoietic Progenitor Kinase 1 by Aberrant Epigenetic Alterations in T Follicular Helper Cells Accounts for Excessive Immunity in Systemic Lupus Erythematosus
Abstract Number: 1222

Drug Response Is Associated with Changes in Specific MicroRNAs in Patients with Rheumatoid Arthritis
Abstract Number: 0911

Drug Retention of Tumor Necrosis Factors and IL-17 Inhibitors in Axial Spondyloarthritis: A Multi-Center Comparative Analysis
Abstract Number: 0516

Dual Fibroblast Transdifferentiation Mediated by Type I Interferon: Application to Anti-Ro Mediated Congenital Heart Block
Abstract Number: PP04

Dual Roles: Thriving with SLE as a Medical Student
Abstract Number: 0177

Dual-Energy Computed Tomography Three Material Decomposition Improves the Sensitivity of Gout Detection
Abstract Number: 0468

During Development of Rheumatoid Arthritis, Intermetatarsal Bursitis May Occur Before Clinical Joint Swelling: A Large MRI Study in Patients with Clinically Suspect Arthralgia
Abstract Number: 1416

Dysregulated Glucose Metabolism and Dyslipidemia in GCA and PMR Patients at Diagnosis
Abstract Number: 0530

Dysregulation of IGFI/IGF1R Pathway and IGF1R+3179A/G Polymorphism in Pathogenesis of Sjögren’s Syndrome